FDB in $300m expansion of US single-use facility
The investment comes as part of a wider $850m global expansion by parent company Fujifilm Corporation of its biologics CDMO subsidiary.
Source: biopharma-reporter.com
Page 7 - Upstream Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Upstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Upstream Processing Today - Breaking & Trending Today
Samsung Biologics and AstraZeneca expand manufacturing partnership
Samsung Biologics will manufacture AstraZeneca’s COVID-19 long-lasting antibody combination (AZD7442) and cancer immunotherapy product from next year under an expanded partnership.
Source: biopharma-reporter.com
Moderna to build mRNA vaccine manufacturing facility in Australia
Moderna and the Australian government have announced an agreement in principle to build a mRNA vaccine manufacturing facility in Victoria, Australia: providing up to 100 million doses a year.
Source: biopharma-reporter.com
CDMO opens microbial-based therapeutics and mRNA vaccines facility in South Australia
This month saw BioCina officially open its new biologics manufacturing facility in Adelaide, Australia, flagging it as the only TGA, EMA, Health Canada and US-FDA approved commercial facility of its kind in the country.
Source: biopharma-reporter.com
New Fujifilm site will cater to cell culture media market demands in China
Fujifilm Irvine Scientific, Inc, is to build a new bioprocessing center in China, with the goal of ensuring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development.
Source: biopharma-reporter.com